Eli Lilly said on Monday it would buy privately held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash.
Source: US Top News and Analysis
Related Posts
How a new Amazon-backed Hollywood production startup deploys AI for speed and cost-cutting
A new AI-powered hybrid Hollywood startup backed by AWS is betting that cutting-edge production tech…
Everything we know about Cole Allen, the D.C. correspondents dinner shooter
Allen was a guest at the Washington Hilton, where the dinner was held, and officials…
FedEx trucking spinoff targets 2026 operating margin of 12%
The trucking company is scheduled to be spun out of FedEx into an independent, publicly…